Seres Therapeutics任命Richard N. Kender为执行董事长兼临时CEO,并同步披露业务进展

美股速递
Mar 03

Seres Therapeutics(股票代码:MCRB)近日宣布,公司已正式任命Richard N. Kender担任执行董事长兼临时首席执行官。与此同时,该公司还对外公布了最新的业务动态与战略进展。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10